Literature DB >> 35646211

Increasing angiotensin-converting enzyme (ACE) 2/ACE axes ratio alleviates early pulmonary vascular remodeling in a porcine model of acute pulmonary embolism with cardiac arrest.

Hong-Li Xiao1, Lian-Xing Zhao2, Jun Yang3, Nan Tong3, Le An3, Guo-Xing Wang1, Miao-Rong Xie1, Chun-Sheng Li1.   

Abstract

BACKGROUND: Acute pulmonary embolism (APE) with cardiac arrest (CA) is characterized by high mortality in emergency due to pulmonary arterial hypertension (PAH). This study aims to determine whether early pulmonary artery remodeling occurs in PAH caused by massive APE with CA and the protective effects of increasing angiotensin-converting enzyme (ACE) 2-angiotensin (Ang) (1-7)-Mas receptor axis and ACE-Ang II-Ang II type 1 receptor (AT1) axis (ACE2/ACE axes) ratio on pulmonary artery lesion after return of spontaneous circulation (ROSC).
METHODS: To establish a porcine massive APE with CA model, autologous thrombus was injected into the external jugular vein until mean arterial pressure dropped below 30 mmHg (1 mmHg=0.133 kPa). Cardiopulmonary resuscitation and thrombolysis were delivered to regain spontaneous circulation. Pigs were divided into four groups of five pigs each: control group, APE-CA group, ROSC-saline group, and ROSC-captopril group, to examine the endothelial pathological changes and expression of ACE2/ACE axes in pulmonary artery with or without captopril.
RESULTS: Histological analysis of samples from the APE-CA and ROSC-saline groups showed that pulmonary arterioles were almost completely occluded by accumulated endothelial cells. Western blotting analysis revealed a decrease in the pulmonary arterial ACE2/ACE axes ratio and increases in angiopoietin-2/angiopoietin-1 ratio and expression of vascular endothelial growth factor (VEGF) in the APE-CA group compared with the control group. Captopril significantly suppressed the activation of angiopoietin-2/angiopoietin-1 and VEGF in plexiform lesions formed by proliferative endothelial cells after ROSC. Captopril also alleviated endothelial cell apoptosis by increasing the B-cell lymphoma-2 (Bcl-2)/Bcl-2-associated X (Bax) ratio and decreasing cleaved caspase-3 expression.
CONCLUSION: Increasing the ACE2/ACE axes ratio may ameliorate pulmonary arterial remodeling by inhibiting the apoptosis and proliferation of endothelial cells after ROSC induced by APE. Copyright: © World Journal of Emergency Medicine.

Entities:  

Keywords:  Acute pulmonary embolism; Angiotensin-converting enzyme; Cardiac arrest; Early pulmonary vascular remodeling

Year:  2022        PMID: 35646211      PMCID: PMC9108909          DOI: 10.5847/wjem.j.1920-8642.2022.052

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  17 in total

Review 1.  Endothelial dysfunction in pulmonary hypertension.

Authors:  Rohit Budhiraja; Rubin M Tuder; Paul M Hassoun
Journal:  Circulation       Date:  2004-01-20       Impact factor: 29.690

2.  Use of the impedance threshold device improves survival rate and neurological outcome in a swine model of asphyxial cardiac arrest*.

Authors:  Ioannis N Pantazopoulos; Theodoros T Xanthos; Ioannis Vlachos; Georgios Troupis; Evangelos Kotsiomitis; Elisabeth Johnson; Apostolos Papalois; Panagiotis Skandalakis
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

3.  Angiotensin-Converting Enzyme 2 Inhibits Apoptosis of Pulmonary Endothelial Cells During Acute Lung Injury Through Suppressing SMAD2 Phosphorylation.

Authors:  Yong Ji; Fengying Gao; Bo Sun; Jing Hao; Zhenwei Liu
Journal:  Cell Physiol Biochem       Date:  2015-04-08

4.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC).

Authors:  Stavros V Konstantinides; Guy Meyer; Cecilia Becattini; Héctor Bueno; Geert-Jan Geersing; Veli-Pekka Harjola; Menno V Huisman; Marc Humbert; Catriona Sian Jennings; David Jiménez; Nils Kucher; Irene Marthe Lang; Mareike Lankeit; Roberto Lorusso; Lucia Mazzolai; Nicolas Meneveau; Fionnuala Ní Áinle; Paolo Prandoni; Piotr Pruszczyk; Marc Righini; Adam Torbicki; Eric Van Belle; José Luis Zamorano
Journal:  Eur Respir J       Date:  2019-10-09       Impact factor: 16.671

5.  Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension.

Authors:  C Orte; J M Polak; S G Haworth; M H Yacoub; N W Morrell
Journal:  J Pathol       Date:  2000-11       Impact factor: 7.996

6.  ROS scavenger decreases basal perfusion pressure, vasoconstriction and NO synthase activity in pulmonary circulation during pulmonary microembolism.

Authors:  R Mizera; D Hodyc; J Herget
Journal:  Physiol Res       Date:  2015-03-24       Impact factor: 1.881

Review 7.  Pathophysiology and treatment of haemodynamic instability in acute pulmonary embolism: the pivotal role of pulmonary vasoconstriction.

Authors:  Y M Smulders
Journal:  Cardiovasc Res       Date:  2000-10       Impact factor: 10.787

8.  Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system.

Authors:  Bishoy Rizkalla; Josephine M Forbes; Zemin Cao; Geoffrey Boner; Mark E Cooper
Journal:  J Hypertens       Date:  2005-01       Impact factor: 4.844

9.  Captopril improves postresuscitation hemodynamics protective against pulmonary embolism by activating the ACE2/Ang-(1-7)/Mas axis.

Authors:  Hong-Li Xiao; Chun-Sheng Li; Lian-Xing Zhao; Jun Yang; Nan Tong; Le An; Qi-Tong Liu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-07-22       Impact factor: 3.000

10.  Characteristics and outcomes of cardiac arrest survivors with acute pulmonary embolism.

Authors:  Abhishek Dutta; Bhupendar Tayal; Kristian Hay Kragholm; Youssef Masmoudi; John Azizian; Lawson Mcdonald; Amandeep Goyal; Peter Sogaard; Waqas T Qureshi
Journal:  Resuscitation       Date:  2020-07-09       Impact factor: 5.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.